로열티 파마 (RPRX)

Panagora Asset Management Inc. Buys 215,142 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

MarketBeat

Shareholders in Royalty Pharma (NASDAQ:RPRX) are in the red if they invested a year ago - Yahoo Sport Australia

Yahoo Sport Australia

Charles Schwab Investment Management Inc. Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Defense World

Amalgamated Bank Sells 3688 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Defense World

National Bank of Canada FI Has $986,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

MarketBeat

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by National Bank of Canada FI - Defense World

Defense World

Teacher Retirement System of Texas Reduces Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Defense World

Victory Capital Management Inc. Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Defense World

Victory Capital Management Inc. Has $7.46 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

MarketBeat

M&T Bank Corp Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Defense World

Torray Investment Partners LLC Increases Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

MarketBeat

(RPRX) Investment Report - Stock Traders Daily

Stock Traders Daily

Royalty Pharma to Present at Upcoming Investor Conferences

GlobeNewswire Inc.

Van ECK Associates Corp Buys 2944 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Defense World

Royalty Pharma plc (NASDAQ:RPRX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Simply Wall St

Simply Wall St

Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results - Yahoo Finance UK

Yahoo Finance UK

Metis Global Partners LLC Invests $375000 in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Defense World

Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com - Defense World

Defense World

Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend - Yahoo Finance UK

Yahoo Finance UK

Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com - MarketBeat

MarketBeat

Royalty Pharma Stock: Solid Start Of The Year, Buy Confirmed (NASDAQ:RPRX) - Seeking Alpha

Seeking Alpha

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight - Yahoo Finance

Yahoo Finance

Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com Australia

Investing.com Australia

Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com

Investing.com

Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com India

Investing.com India

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab - citybiz

citybiz

Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Zacks Investment Research

Zacks Investment Research

Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Yahoo Finance

Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

Yahoo Finance

Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates - Zacks Investment Research

Zacks Investment Research

Royalty Pharma Reports First Quarter 2024 Results - 09.05.2024 - wallstreet:online

wallstreet:online

Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Sanofi's (SNY) Frexalimab - StreetInsider.com

StreetInsider.com

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

GlobeNewswire Inc.

The Best Healthcare Stocks to Buy - Morningstar

Morningstar

Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Surpass Estimates

Zacks Investment Research

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Swiss National Bank - MarketBeat

MarketBeat

Why Earnings Season Could Be Great for Royalty Pharma (RPRX) - Zacks Investment Research

Zacks Investment Research

RPRX Breaks Above 3% Yield Territory - Nasdaq

Nasdaq

Why Earnings Season Could Be Great for Royalty Pharma (RPRX)

Zacks Investment Research

RPRX Breaks Above 3% Yield Territory - Nasdaq

Nasdaq

Russell Investments Group Ltd. Purchases 54,907 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

MarketBeat

Royalty Pharma (RPRX) Scheduled to Post Quarterly Earnings on Thursday - Defense World

Defense World

Royalty Pharma plc (NASDAQ:RPRX) Receives $46.75 Consensus Target Price from Analysts - MarketBeat

MarketBeat

Royalty Pharma (RPRX) Scheduled to Post Quarterly Earnings on Thursday - Defense World

Defense World

Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics

Zacks Investment Research

Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics - Nasdaq

Nasdaq

Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics - Zacks Investment Research

Zacks Investment Research

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by First Trust Direct Indexing L.P. - Defense World

Defense World